4-IMIDAZOPYRIDAZIN-1-YL-BENZAMIDES AND 4-IMIDAZOTRIAZIN-1-YL-BENZAMIDES AS BTK-INHIBITORS

摘要

There are provided 6-5 membered fused pyridine ring compounds according to formula l (see formula I) or a pharmaceutically acceptable salt thereof or to pharmaceutical compositions comprising these compounds and their possible use in therapy. The disclosure relates to the use of 6-5 membered fused pyridine ring compounds according to formula l for inhibiting Bruton's Tyrosine Kinase (Btk) in vitro which may allow the treatment of Bruton's Tyrosine Kinase (Btk) mediated disorders.